The client needed to comply with the European Union’s Falsified Medicines Directive (EU FMD) and the U.S. Drug Supply Chain Security Act (DSCSA), as well as Russian and Saudi Arabian regulations. In addition, because their products are lifesaving, the mandate was to get the serialized product to the patient in the acceptable packaging on time. Learn more by downloading our complete Case Study.
COMPLETE THIS FORM TO ACCESS YOUR CONTENT 